1. FDA sees only slight dip in device approvals during pandemic — Novartis' Novartis to provide 'no profit' COVID drugs to low income countries — Relay Therapeutics prices IPO at $400M — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Xeris Pharma

Anonymous board for Xeris Pharma


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    7
    Views:
    678
  2. anonymous
    Replies:
    2
    Views:
    129
  3. anonymous
    Replies:
    11
    Views:
    1,995
  4. anonymous
    Replies:
    5
    Views:
    350
  5. anonymous
    Replies:
    14
    Views:
    1,683
  6. anonymous
    Replies:
    11
    Views:
    2,173
  7. anonymous
    Replies:
    23
    Views:
    2,752
  8. anonymous
    Replies:
    6
    Views:
    1,268
  9. anonymous
    Replies:
    26
    Views:
    2,267
  10. anonymous
    Replies:
    0
    Views:
    413
  11. anonymous
    Replies:
    4
    Views:
    1,422
  12. anonymous
    Replies:
    1
    Views:
    969
  13. anonymous
    Replies:
    1
    Views:
    718
  14. anonymous
    Replies:
    1
    Views:
    735
  15. anonymous
    Replies:
    4
    Views:
    828
  16. anonymous
    Replies:
    3
    Views:
    1,036
  17. anonymous
    Replies:
    2
    Views:
    830
  18. anonymous
    Replies:
    8
    Views:
    1,917
  19. anonymous
    Replies:
    50
    Views:
    7,127
  20. anonymous
    Replies:
    12
    Views:
    2,063

Thread Display Options

Loading...